Short-Term Responders of Non-Small Cell Lung Cancer Patients to EGFR Tyrosine Kinase Inhibitors Display High Prevalence of TP53 Mutations and Primary Resistance Mechanisms.
Translational Oncology
Xu, Yanjun Y; Tong, Xiaoling X; Yan, Junrong J; Wu, Xue X; Shao, Yang W YW; Fan, Yun Y
Publication Date: 2018-12
Variant appearance in text: ARID1A: 936_965delCGGGGGCGACTACAGTGGCGGGCCCCAGGA